- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 07-04-2026: Press Release
07-04-2026 | 06:14 pm
07-04-2026 | 06:14 pm
Aurobindo Pharma secured USFDA approval for Dapagliflozin Tablets (5 mg & 10 mg), a generic equivalent to Farxiga. With an estimated market size of US$ 10.2 billion, the company gets 180 days of shared generic exclusivity and plans immediate launch, strengthening its diabetes segment.
No comments yet. Be the first to comment!